Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors/therapeutic use
Antibodies, Monoclonal, Humanized/*therapeutic use
Antineoplastic Agents/*therapeutic use
Bevacizumab
Carcinoma, Non-Small-Cell Lung/*drug therapy/mortality/pathology
Disease-Free Survival
Drug Therapy, Combination
Europe/epidemiology
Female
Follow-Up Studies
Humans
Lung Neoplasms/*drug therapy/mortality/pathology
Male
Middle Aged
Prospective Studies
Survival Rate/trends
Time Factors
Treatment Outcome
United States/epidemiology
Vascular Endothelial Growth Factor A
